Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone
Complementary, Not Competing Yes, you can take bothand they may actually work better together
At MDWatch, compounded GLP1 is dispensed by licensed U.S
Boost Your Self-Confidence If you are unhappy with your weight and it has caused your self-confidence to plummet, you are not alone
Additionally, emerging data supports the complementary use of both drug classes, revealing additive benefits on cardiovascular and renal outcomes without increased toxicity
The starting phases exist to train your GI system